Abstract:OBJECTIVE: Idiopathic pulmonary fibrosis (IPF) is associated with the occurrence and progress of the proliferation and activation of lung fibroblast. Recent studies have shown that microRNA-340-5p (miR-340-5p), a member of miRNA family, has modulated the skin fibroblast proliferation in scar formation disease. However, it is elusive whether miR-340-5p exert a pulmonary anti-fibrotic effect on IPF by moderating fibroblast bioactivity. The present study aimed to investigate the role of Adam10 in lung fibroblast regulation. MATERIALS AND METHODS: Human lung fibroblasts were carried out Transforming Growth factor-beta (TGF-beta) to stimulate proliferation and activation. MiR-340-5p mimics or inhibitor loaded in pcDNA3.1 aimed at overexpression or inhibition were respectively delivered to lung fibroblast using Lipofectamine 2000 for transfection. Then, siRNA-ATF1 (Activating transcription factor 1) was utilized to knockdown ATF1 expression in lung fibroblast after miR-340-5p overexpression and probed the role of ATF1 in lung fibroblast. Western blotting, Reverse Transcription-Polymerase Chain Reaction (RT-PCR), Dual-Luciferase reporter system, Cell Counting Kit-8 (CCK-8) assay, scratch assay, and immunofluorescence were conducted to measure the alteration of miR-340-5p, ATF1, and fibrosis-relative level. RESULTS: We find that the expression of miR340-5p markedly increases or decreases in fibroblast after mimics or inhibitor transfection respectively. Moreover, we demonstrate that the overexpression of miR-340-5p reduces the expression of ATF1 to prevent fibroblast activation and proliferation by targeting ATF1 and restrain MAPK/p38 pathway following TGF-beta stimuli. CONCLUSIONS: The above proved that the increased miR-340-5p ameliorates the activation and proliferation of lung fibroblast in fibrosis process via targeting ATF1 and MAPK/p38 pathway. Our research provides novel insight on the miRNA modulation of process of TGF-beta stimuli in lung fibroblast and verifies a potential target for the therapy of lung fibrosis in the future.

MicroRNA-30d/JAG1 Axis Modulates Pulmonary Fibrosis Through Notch Signaling Pathway

miR-627/HMGB1/NF-κB regulatory loop modulates TGF-β1-induced pulmonary fibrosis.

microRNA-30a attenuates TGF-β1-induced activation of pulmonary fibroblast cell by targeting FAP-α.

Regulation of idiopathic pulmonary fibrosis: a cross-talk between TGF- β signaling and MicroRNAs

miR-205 Suppresses Pulmonary Fibrosis By Targeting GATA3 Through Inhibition Of Endoplasmic Reticulum Stress.

MicroRNA‐448 overexpression inhibits fibroblast proliferation and collagen synthesis and promotes cell apoptosis via targeting ABCC3 through the JNK signaling pathway

Mir-301A Suppression Within Fibroblasts Limits the Progression of Fibrosis Through the TSC1/mTOR Pathway

MiR-340-5p mitigates the proliferation and activation of fibroblast in lung fibrosis by targeting TGF-/p38/ATF1 signaling pathway

Mir-29 Inhibits Bleomycin-induced Pulmonary Fibrosis in Mice

MiR-338* Suppresses Fibrotic Pathogenesis in Pulmonary Fibrosis Through Targeting LPA1.

MiRNA, a New Treatment Strategy for Pulmonary Fibrosis

Regulation Mechanism of Microrna-29 on Transforming Growth Factor-Β1/smad3 Pathway in Pulmonary Fibrosis

Mmu-Microrna-92a-3p Attenuates Pulmonary Fibrosis by Modulating Cpeb4-mediated Smad2/3 Signaling Pathway

Myeloid Fbxw7 Prevents Pulmonary Fibrosis by Suppressing TGF-beta Production

MiR-338* targeting smoothened to inhibit pulmonary fibrosis by epithelial-mesenchymal transition.

Mir-34A Inhibits Lung Fibrosis by Inducing Lung Fibroblast Senescence.

MicroRNA-489-3p Represses Hepatic Stellate Cells Activation by Negatively Regulating the JAG1/Notch3 Signaling Pathway

Mir-146b Expression Is Upregulated In The Lung Of Pulmonary Fibrosis Mice

MicroRNA‑375 Prevents TGF‑β‑dependent Transdifferentiation of Lung Fibroblasts Via the MAP2K6/P38 Pathway

CircHIPK3 regulates pulmonary fibrosis by facilitating glycolysis in miR-30a-3p/FOXK2-dependent manner

MicroRNA-155 inhibits the pro-fibrogenic activities of TGF-β 1 in human lung fibroblasts